BRANY (Biomedical Research Alliance of New York) research sites now have the opportunity to improve their patient stipend payments and manage their study budgets with a discount from Greenphire’s ClinCard System.
The ClinCard System is a fully configurable and primarily web-based technology, designed to comply with all applicable regulation and enabling sites and sponsors to deliver subject payments (stipends, travel reimbursements, and other ad-hoc payments) in a controlled and automated manner in compliance with industry regulation and in accordance with the specific requirements of each study.
“BRANY’s partnership with Greenphire is a natural extension of our suite of services to our alliance members,” says BRANY’s Carmela Houston-Henry, Director of Sales and Business Development. “Our members benefit from efficiency in managing their study budgets, and study participants receive expedited stipend payments.”
Recently Montefiore Medical Center, the University Hospital for Albert Einstein College of Medicine became the 100th study site to implement the ClinCard system. Montefiore joins a large and established base of sites and more than 20 sponsors and CROs in realizing the ClinCard’s benefits to the clinical trials process. By automating patient stipend payments, reimbursements, and communication through a web-based portal, Greenphire’s innovative technologies enhance the patient experience and improve patient retention, reduce administration associated with patient payments and communication for both site and sponsor users, and centralize reporting, tracking, and auditing of stipends and reimbursements.
The Biomedical Research Alliance of New York (BRANY) is a national organization providing support services to sponsors and investigators involved in research in a wide variety of therapeutic areas, medical devices, biologic and diagnostic trials. Staffed by multi-disciplinary experts, BRANY is an expedited "end-to-end solution" for clinical trials.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.